SCHEMBL25398289

SCHEMBL25398289

CCCCn1cnc2c1C(=O)c1ccccc1/C2=N\O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 2/20 0.41
▸ ALDH1A1 P00352 9/20 0.38
▸ NPC1 O15118 5/20 0.38
▸ RAB9A P51151 5/20 0.38
▸ HPGD P15428 3/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ SMN1; SMN2 Q16637 4/20 0.38
▸ MAPT P10636 3/20 0.38
▸ MITF O75030 2/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ PKM P14618 1/20 0.38
▸ RECQL P46063 1/20 0.38
▸ AURKA O14965 1/20 0.37
▸ KDR P35968 1/20 0.37
▸ AURKB Q96GD4 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ NPSR1 Q6W5P4 2/20 0.37
▸ NFKB1 P19838 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25398292 1.00 IDO1 (0.41) IDO1ALDH1A1NPC1RAB9AHPGD
SCHEMBL25395384 0.93 IDO1 (0.42) IDO1ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL25395376 0.93 IDO1 (0.42) IDO1ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL25434292 0.90 IDO1 (0.44) IDO1ALDH1A1SMN1; SMN2MAPTMITF
SCHEMBL25434297 0.90 IDO1 (0.44) IDO1ALDH1A1SMN1; SMN2MAPTMITF
SCHEMBL25435666 0.86 IDO1 (0.41) IDO1ALDH1A1NPC1RAB9AHPGD
SCHEMBL26252221 0.86 IDO1 (0.41) IDO1ALDH1A1NPC1RAB9AHPGD
SCHEMBL25435669 0.86 IDO1 (0.41) IDO1ALDH1A1NPC1RAB9AHPGD
SCHEMBL7092926 0.86 ALDH1A1 (0.50) IDO1ALDH1A1NPC1RAB9AHPGD
SCHEMBL25433052 0.85 USP8 (0.41) IDO1ALDH1A1NPC1RAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116768801-B Condensed quinone oxime imidazoles and their onium derivatives, their preparation and use 上海交通大学 2026-05-19 — — CN disclosed
US-20250163002-A1 FUSED QUINONOXIME IMIDAZOLE, ONIUM DERIVATIVES THEREOF, PREPARATION AND USE THEREOF SHANGHAI JIAO TONG UNIVERSITY (CN) 2025-05-22 — — US disclosed
EP-4484412-A1 FUSED QUINONE OXIME IMIDAZOLE, ONIUM DERIVATIVE THEREOF, PREPARATION THEREFOR AND USE THEREOF Shanghai Jiao Tong University (CN) 2025-01-01 — — EP disclosed
CN-116768801-A Condensed quinone oxime imidazoles and their onium derivatives, their preparation and use 上海交通大学 2023-09-19 — — CN disclosed
WO-2023168908-A1 FUSED QUINONE OXIME IMIDAZOLE, ONIUM DERIVATIVE THEREOF, PREPARATION THEREFOR AND USE THEREOF 上海交通大学 2023-09-14 — — WO disclosed
WO-2023168908-A1 FUSED QUINONE OXIME IMIDAZOLE, ONIUM DERIVATIVE THEREOF, PREPARATION THEREFOR AND USE THEREOF 上海交通大学 2023-09-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250163002-A1 FUSED QUINONOXIME IMIDAZOLE, ONIUM DERIVATIVES THEREOF, PREPARATION AND USE THEREOF SQOR, NDUFV2, NDUFV1 IDO1 54/4885ALDH1A1 1568/4885NPC1 4703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback